Ch. du Vernay 14a
CH-Vaud
1196 Gland
info@neumarz.com
+41.21.561.34.96
Back

Kainjoo Inc. Opens New US Offices after a 10 years presence in Europe

New York, NY, July 21, 2024Kainjoo Inc, a US subsidiary of the Swiss-based Kainjoo Group, is proud to announce the establishment of its new office in New York City, marking a significant milestone in the company’s global expansion strategy. This move aims to enhance our presence in North America and structure our market operations overseas. Kainjoo Inc., renowned for its expertise in programmatic advertising and deep knowledge of regulated industries, is now operational in New York. The company is rapidly expanding its reach to the Florida states, leveraging its robust network of partners and clients.

  • Trusted by Industry Leaders: Kainjoo Inc. has built a reputation for excellence and is trusted by leading companies such as Ferring Pharmaceuticals, Thermo Fisher, Abbott, and Medtronic.
  • Managing Allegory Capital’s $50M 2k32 Fund: Kainjoo is the management company for Allegory Capital’s $50M fund, designed to support regulated industries in acquiring or investing in tech ventures.
  • Expanding Footprint in North America: Kainjoo Inc.’s new office in New York City represents a strategic effort to tap into the shifting marketing gravity centre for global brands, which recently moved from European headquarters to the U.S.

Industry Leaders Trust Kainjoo in Regulated Industries.

Kainjoo Inc. has built a reputation for excellence and is trusted by leading companies such as Ferring Pharmaceuticals, Thermo Fisher, Abbott, and Medtronic. It has served US customers since its opening in 2012. These clients have recognized Kainjoo’s unique ability to navigate complex regulatory landscapes and deliver impactful advertising strategies tailored to their needs. For example, Kainjoo’s work with Abbott has involved developing targeted marketing campaigns that adhere to strict healthcare regulations, ensuring compliance while maximizing reach and engagement. “Kainjoo’s innovative approach has significantly improved our outreach while maintaining compliance with healthcare standards,” said Haider Alleg, Founder of Kainjoo and General Partner at Allegory Capital.

Kainjoo Inc.

Kainjoo will be managing Allegory Capital’s $50M 2k32 Fund

Kainjoo is the management company for Allegory Capital’s $50M 2k32 fund, designed to support regulated industries acquiring or investing in tech ventures. This strategic initiative underscores Kainjoo’s dedication to fostering innovation and growth within its client base. Allegory Capital aims to bridge the gap between regulated industries and technological advancements, providing the financial support to drive digital transformation. For instance, by managing Allegory Capital, Kainjoo can help healthcare companies invest in new technologies that improve patient care and streamline operations. “The collaboration with Kainjoo through Allegory Capital has enabled us to explore and integrate cutting-edge solutions that enhance our service delivery,” said Haider Alleg.

Kainjoo is Expanding Footprint in North America

Kainjoo Inc’s new office in New York City represents a strategic effort to tap into the shifting marketing gravity centre for global brands, which has recently moved from European headquarters to the U.S. By following this customer trend, Kainjoo is establishing a long-overdue presence in the U.S., aligning itself with the needs of its global teams. The firm already serves prominent U.S. customers such as Ferring Pharmaceuticals, Thermo Fisher, Abbott, and Medtronic. This expansion supports Kainjoo’s commitment to serve its clients better and capitalize on the growing market opportunities in North America. Given the increasing demand for advanced advertising solutions in the regulated sectors, the company’s decision to establish a presence in New York City is strategic and timely. New York City, known for its dynamic business environment and strategic importance, offers Kainjoo the perfect platform to expand its footprint and enhance its service delivery. “Establishing our office in New York City allows us to be closer to our U.S. clients and respond more swiftly to their needs,” said Haider Alleg. This strategic move reflects Kainjoo’s adaptability and forward-thinking approach, ensuring they remain at the forefront of industry developments and continue to provide top-tier services to their clients. Kainjoo is poised to leverage new opportunities and foster growth in North America by positioning itself in this key market.

Kainjoo Inc.

What Makes Kainjoo Unique

Kainjoo’s uniqueness lies in its blend of data-driven technology solutions, creative branding, and emotional marketing. This integrated approach allows Kainjoo to take brands from strategic imperatives to operational excellence and build teams to support the placement of these companies in the commercial orbit. “Our unique blend of technology, creativity, and emotional engagement positions us to offer unparalleled support to our clients,” said Haider Alleg. Kainjoo heavily utilizes Japanese continuous progress techniques such as Kaizen and Six Sigma to optimize brand footprints, explaining the attachment to Japan. Kainjoo culturally connects well with Japanese working culture and has supported companies such as Hoya, Seiko, Sunstar, and many more. This holistic approach ensures that Kainjoo can deliver comprehensive solutions that drive growth and success for its clients in complex and regulated environments.

Future Expansion Plans for the Kainjoo Group

To be closer to our customers and leverage our global business expertise, Kainjoo Inc. will enable ventures like Galinea, a project created by Kainjoo and supported by Allegory Capital, to benefit from this opening. Galinea offers health and hygiene brands an expanded reach in the US market for export and will continue its global expansion, with China being next on the map. Additionally, Kainjoo aims to cover the Middle East market, with clients in Jordan and Dubai already undergoing significant developments. This strategic expansion highlights Kainjoo’s commitment to providing comprehensive support to brands on a global scale.

Moreover, the company is already actively recruiting Brand-Tech Specialists for different customers. Check the Kainjoo Careers site for more information about open vacancies.

Kainjoo Inc.

About Kainjoo Inc.

Kainjoo is a global brand-tech firm based in Switzerland. Specializing in regulated industries, Kainjoo excels in transforming commercial operations by integrating emerging technologies and innovative branding strategies. The firm combines strategic consulting, operational excellence, and continuous improvement methodologies such as Kaizen and Six Sigma to deliver exceptional customer experiences. With a unique model that merges creative thinking, emotional marketing, and technology engineering, Kainjoo supports its clients in navigating complex regulatory environments and achieving measurable business performance.


Contact Information:

Kainjoo Inc
Head Office: 14th Wall Street, New York, NY 10005, United States
Email: us@kainjoo.com
Phone: +1 201-614-7849
Website: kainjoo.com

Leave a Reply

Your email address will not be published. Required fields are marked *

Legal Disclaimer

Investments involve a high degree of risk.

Investors should carefully consider the risks described & all other information in the investor agreement provided to you before deciding whether to invest in the proposal.

Participation and investment are speculative activities that involve a high degree of financial risk. Certain risk factors that should be considered in assessing an investment in Neumarz (an Allegory Capital & Kainjoo SA brand) and its activities include, but are limited to, those set out below.

Any one or more of these risks could have a material adverse effect on the value of any investment in Neumarz, an Allegory Capital & Kainjoo SA brand, and the business, financial position or operating results of Neumarz, an Allegory Capital & Kainjoo SA brand.

An investor may lose all or part of his or her investment in Neumarz, an Allegory Capital & Kainjoo SA brand.

Additional risks and uncertainties not currently known to the officers and directors of Neumarz, an Allegory Capital & Kainjoo SA brand, may also adversely affect current activities. The information below is not an exhaustive summary of the risks affecting Neumarz, an Allegory Capital & Kainjoo SA brand. It is not intended to be presented in any assumed order of priority. The hazards relating to the business of Neumarz, an Allegory Capital & Kainjoo SA brand, include, among other things:

(a) there are no assurances that Allegory Capital  or Kainjoo SA will earn profits in the future or that profitability will be sustained;

(b) there are no assurances that Allegory Capital  or Kainjoo SA will have access to sufficient funding for future operations or to fulfil its obligations under current agreements;

(c) risks that are inherent to investments, including (i) the valuation of these assets is subject to significant volatility, (ii) the regulatory regime governing venture capital investments is uncertain, and new regulations or policies may materially adversely affect the development of investment, (iii) the further development of businesses are subject to a variety of factors that are difficult to evaluate, (iv) companies and intangible assets are at risk of security breaches, (v) potential loss or destruction due to cybersecurity threats, and (vi) risks of an illiquid market for assets;

(d) difficulty in valuing investments;

(e) Allegory Capital and Kainjoo SA have limited operating history, and there is no assurance that the investments of Allegory Capital will be profitable;

(f) Allegory Capital has not generated revenues to date, and there can be no guaranteed return on its investments;

(g) directors, officers and key employees may resign from Allegory Capital ;

(h) Allegory Capital is unable to insure against every risk to which it is exposed;

(i) Laws relating to the business of Allegory Capital may be changed in a manner which adversely affects Allegory Capital ;

(j) Allegory Capital may invest in entities with no operating history, making evaluating such entities complex and

(k) Risk related to foreign exchange rates.

Additional risks and uncertainties not presently known to Allegory Capital and Kainjoo SA or that it currently deems immaterial may substantially affect its business, financial condition, valuations, trading performance and prospects.

Potential investors are accordingly advised to consult an independent financial adviser who specializes in advising on investments of this kind before making any investment decisions in Allegory Capital or Kainjoo SA.

A prospective investor should consider whether an investment in Allegory Capital or Kainjoo SA is suitable in light of his or her circumstances and the available financial resources.